Ocular Implants Market (2025-2032)
The Ocular Implants Market is expected to reach $23.43 billion by 2032, at a CAGR of 6.1% from 2025 to 2032.
- Published
- Sep 2024
- Pages
- 240
- Format
- PDF + Excel
- Report ID
- MRHC - 1041245
- Base year
- 2024
- 2032 · FORECAST
- $23.43B
- 2032
- $23.43B
- CAGR 2025–2032
- 6.1%
2024 baseline · 2025–2032 forecast at 6.1% CAGR · hover a bar for the value
Key highlights
By Type: The Functional Implants Segment to Dominate the Market in 2025
By Material: The Inert Materials Segment to Dominate the Market in 2025
By Application: The Glaucoma Surgery Segment to Dominate the Market in 2025
By End User: The Hospitals Segment to Dominate the Market in 2025
By Region: North America to Dominate the Ocular Implants Market in 2025
Report summary
| Particulars | Details |
|---|---|
| Number of Pages | 240 |
| Format | |
| Forecast Period | 2025–2032 |
| Base Year | 2024 |
| CAGR (Value) | 6.1% |
| Market Size (Value) | USD 23.43 Billion by 2032 |
| Segments Covered | By Type · Non Functional Implants · Ocular Implants · Scleral shells · Stock Shells · Custom-made prosthesis · Orbital Implants · Functional Implants · Intraocular Lens · Glaucoma Implants · Retinal Implants · Corneal Implants · By Material · Inert Materials · Glass · Silicone · Methylmethacrylate · Biointegrated Materials · Hydroxyapatite · Porous Polyethylene · Aluminum Oxide · By Application · Ocular Prosthesis · Glaucoma Surgery · Oculoplasty · Drug Delivery · Other Applications · (Note: Other end applications include vision correction, cosmetic surgery, and age-related macular degeneration.) · By End User · Hospitals · Ophthalmic Clinics · Ambulatory Surgery Centers (ASCs) · Other End Users · (Note: Other end users include academic & research institutes and pharmaceutical & biotechnology companies.) |
| Regions/Countries Covered | North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, Netherlands, Switzerland, Sweden, Belgium, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentina, and Rest of Latin America), and the Middle East & Africa. |
| Key Companies Profiled | Alcon Inc. (Switzerland), Bausch + Lomb Corporation (Canada), Carl Zeiss AG (Germany), Johnson & Johnson Vision Care, Inc. (U.S), STAAR SURGICAL COMPANY (U.S), Morcher GmbH (Germany), HOYA CORPORATION (Japan), GLAUKOS CORPORATION (U.S), AbbVie Inc. (U.S.), and Vivani Medical Inc. (U.S). |
Report overview
Segments covered: type, non functional implant, ocular implant, scleral shell, stock shell, custom-made prosthesis, orbital implant, functional implant, intraocular len, glaucoma implant, retinal implant, corneal implant, material, inert material, glass, silicone, methylmethacrylate, biointegrated material, hydroxyapatite, porous polyethylene, aluminum oxide, application, ocular prosthesis, glaucoma surgery, oculoplasty, drug delivery, other application, end user, hospital, ophthalmic clinic, other end user. Regions: North America, Europe, Asia-Pacific, Latin America.
The growth of the ocular implants market is driven by the increasing geriatric population coupled with the high prevalence of eye diseases, the rising adoption of minimally invasive surgeries, increasing healthcare expenditure, technological advancements in ocular implants, increasing accident cases, and the rising need for ocular implants. However, the risk of post-surgery infection and inflammation, lack of skilled ophthalmic surgeons, and strict regulations and approval processes restrain the growth of this market.
Additionally, the lack of awareness in rural areas, technological complexities, high implant costs, and increasing product recalls are major challenges for the players operating in this market. Furthermore, biomaterial-based ocular implants, AI-driven 3D printed prosthetic eyes, and drug-eluting implants are trends in the ocular implants market.
Report infographic
Market dynamics
5 factors across 3 forcesRising Geriatric Population Coupled with High Prevalence of Eye Diseases
The rising geriatric population has become a concern in several countries globally. This increase is attributed to the increasing life expectancy, declining fertility rates, and improvements in the quality of healthcare resulting in greater survival rates. According to the World Health Organization (WHO), by 2032, one in 6 people globally will be aged 60 years or above. In 2022, the elderly population reached nearly 1.4 billion from 1 billion in 2020. This number is expected to increase further to 2.1 billion by 2050.
The geriatric population is more prone to eye diseases due to weakened immune systems, age-related macular degeneration (AMD), and other diseases. Also, cataracts impact more than 20.5 million Americans aged 40 and older, and 6.1 million Americans have had cataract surgery. (Source: American Academy of Ophthalmology). Such instances are expected to drive the growth of the ocular implants market.
Technological Advancements in Ocular implants
The number of companies that have developed ocular implants has increased significantly over the past decade. Recently, material selection and implant design criteria have progressed from nonporous polymeric spheres to devices with more advanced shapes and complicated functions for ensuring improved clinical results. Due to their highly interconnected design, polymeric and ceramic implants have gained popularity for fibrovascular ingrowth, with depleted obstacle rates provided with improved options for setting prosthetic eye mobility. Additionally, numerous bio-ceramic compositions are currently demonstrated and have resulted in the capacity to bind to soft tissue and promote angiogenesis, making these materials compatible with several soft tissue applications, including eye operation that was earlier unimaginable. Such advancements are expected to drive the ocular implants market.
Table of contents
12 chapters · 122 sections · 240 pages · click to expandSegmental analysis
| Segment | Largest share (2025) | Fastest growth (2025–2032) |
|---|---|---|
| By Type | Functional Implants | — |
| By Material | Inert Materials | — |
| By Application | Glaucoma Surgery | — |
| By End User | Hospitals | — |
By Type
- The functional implants segment is expected to account for the largest share of 81.7% of the ocular implants market.
- The use of functional implants in cosmetic reconstructions, the ability of functional implants to support eye movements, the advantages of functional implants such as their increasing availability and considerable cost, and the high prevalence of eye diseases and disorders contribute to the segment’s large share.
By Material
- The Inert Materials Segment to Dominate the Market in 2025
- The inert materials segment is further segmented into glass, silicone, and methylmethacrylate.
- The inert materials segment is expected to account for the largest share of the ocular implants market.
- The large market share of this segment can be attributed to the cost-effectiveness of inert materials and the high preference for glass and silicone material-based ocular implants due to their high compatibility and excellent visual appearance.
By Application
- The Glaucoma Surgery Segment to Dominate the Market in 2025
- The glaucoma surgery segment is expected to account for the largest share of 32.6% of the ocular implants market.
- The large market share of this segment can be attributed to the large number of patients affected by glaucoma coupled with increasing cases of glaucoma among the geriatric population and the availability of glaucoma treatment facilities.
- For instance, according to the October 2022 report of National Glaucoma Research (U.S.), more than 3 million individuals in the U.S. are living with glaucoma, out of which 2.7 million are aged 40 and older.
- Such instances are expected to support the largest share of the segment.
By End User
- The Hospitals Segment to Dominate the Market in 2025
- The hospitals segment is expected to account for the largest share of the ocular implants market.
- The large market share of this segment can be attributed to the easy accessibility to hospitals, the high preference towards hospitals from patients as the first choice for diagnosis and therapies, and the availability of advanced instruments in hospitals.
Geographic analysis
North America
Largest shareIn 2025, North America is expected to account for the largest share of 41.8% of the ocular implants market, followed by Europe and Asia-Pacific. In North America, the U.S. is expected to account for the largest share in 2025, mainly due to high healthcare expenditure, growth in the aging population, favorable government policies, and the presence of key players in the region. By Region: North America to Dominate the Ocular Implants Market in 2025
Asia-Pacific
Fastest growthHowever, Asia-Pacific is slated to register the highest growth rate of 6.3% during the forecast period 2025–2032 due to growing economies such as India and China. The growth of the ocular implants market in Asia-Pacific is also driven by the increasing geriatric population, the rising prevalence of eye diseases such as glaucoma, infectious endophthalmitis, and other eye diseases, and increasing healthcare expenditures. Rising cases of eye injuries are likely to increase the demand for ocular implants, driving market growth. For instance, according to the Indian Journal of Ophthalmology, eye injuries constitute approximately 38%–65% of emergency cases in hospitals. Thus, the increasing cases of eye injuries are expected to support the growth of the ocular implants market in the region.
Competitive landscape
- March 2022
Staar Surgical Company (U.S.) received FDA approval for the EVO/EVO+ Visian Implantable Collamer Lens to correct myopia and myopia with astigmatism.
- August 2024
HumanOptics Holding AG (Germany) launched ARTIFICIALIRIS SELECT, a premium implant in nine predefined color combinations for urgent and fast patient care.
- December 2024
Glaukos Corporation (U.S.) received FDA approval for the drug-releasing implant designed for reducing intraocular pressure in individuals with ocular hypertension.
- March 2020
Allergen, a part of AbbVie Inc. (U.S.), received FDA approval for biodegradable implants for eye conditions, including ocular hypertension and open-angle glaucoma.
- Alcon Inc. · Switzerland
- Bausch + Lomb Corporation · Canada
- Carl Zeiss AG · Germany
- Johnson & Johnson Vision Care, Inc. (U.S)
- STAAR SURGICAL COMPANY (U.S)
- Morcher GmbH · Germany
- HOYA CORPORATION · Japan
- GLAUKOS CORPORATION (U.S)
- AbbVie Inc. (U.S.)
- Vivani Medical Inc. (U.S)
Frequently asked questions
The ocular implants market refers to the global industry focused on producing medical devices implanted in the eye, used for treating various eye disorders, including glaucoma, cataracts, and macular degeneration.
Cite this report
Meticulous Research. (2024). Ocular Implants Market - Global Opportunity Analysis and Industry Forecast (2025-2032) (Report No. MRHC - 1041245). Meticulous Market Research Pvt. Ltd. https://www.meticulousresearch.com/product/ocular-implants-market-5928